Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid

Share this content:
Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid
Vi-Tetanus Toxoid Conjugate Vaccine Can Prevent Typhoid

FRIDAY, Sept. 29, 2017 (HealthDay News) -- A Vi-tetanus toxoid conjugate vaccine is efficacious for prevention of typhoid fever, according to a study published online Sept. 28 in The Lancet.

Celina Jin, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues examined the efficacy of a Vi-tetanus toxoid conjugate vaccine using an established human infection model of Salmonella enterica serovar Typhi (S Typhi). Healthy adult volunteers (aged 18 to 60 years) were recruited and randomized in a 1-to-1-to-1 ratio to receive a single dose of Vi-conjugate (Vi-TT; 37 participants), Vi-polysaccharide (Vi-PS; 35 participants), or control meningococcal vaccine (31 participants). Participants orally ingested S Typhi and were assessed with daily blood culture over a two-week period.

The researchers found that 77, 35, and 35 percent of participants in the control, Vi-TT, and Vi-PS groups met the composite criteria for typhoid diagnosis, respectively, giving vaccine efficacies of 54.6 and 52 percent for Vi-TT and Vi-PS. In Vi-TT and Vi-PS participants, seroconversion was 100 and 88.6 percent, respectively; Vi-TT vaccine recipients had significantly higher geometric mean titers detected one month post-vaccination.

"Vi-TT is a highly immunogenic vaccine that significantly reduces typhoid fever cases when assessed using a stringent controlled model of typhoid infection," the authors write. "Vi-TT use has the potential to reduce both the burden of typhoid fever and associated health inequality."

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

Study Finds 31 Percent Use No Opioids After Surgery

Study Finds 31 Percent Use No Opioids After ...

At discharge, 92.2 percent of patients received an opioid prescription; nearly 63 percent unused

PAs May Have Lower Diagnostic Accuracy for Melanoma

PAs May Have Lower Diagnostic Accuracy for Melanoma

PAs diagnose fewer melanomas in situ, perform more skin biopsies per case of skin cancer diagnosed

AAN: Neuromodulation Therapy Gives Relief From Hand Tremor

AAN: Neuromodulation Therapy Gives Relief From Hand Tremor

Non-invasive neuromodulation therapy using a custom stimulation pattern safe for essential tremor

is free, fast, and customized just for you!

Already a member?

Sign In Now »